Literature DB >> 9834285

Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice.

L Mohr1, S Tanaka, J R Wands.   

Abstract

BACKGROUND & AIMS: Long-term ethanol consumption is known to impair the ability of the liver to regenerate, but the molecular mechanisms are poorly understood. Multiple growth factors promote hepatocyte proliferation, some of which involve the insulin receptor substrate 1 (IRS-1)-mediated signal transduction pathway. To explore effects of ethanol on the IRS-1 signal liver growth in vivo, studies in transgenic mice overexpressing IRS-1 in the liver were performed because these mice show constitutive activation of the downstream signal transduction pathways leading to enhanced hepatocyte proliferation.
METHODS: Tyrosyl phosphorylation of IRS-1 and subsequent protein-protein interactions were examined in liver lysates from animals fed ethanol or control diet. Activity of phosphatidylinositol-3 kinase (PI3K) and mitogen-activated protein kinase (MAPK) was assessed by specific enzymatic assays. Hepatocyte proliferation was measured by incorporation of [3H]thymidine into liver DNA.
RESULTS: Tyrosyl phosphorylation of IRS-1, association of IRS-1 with PI3K, and activation of downstream PI3K and MAPK pathways were greatly reduced as a result of long-term ethanol consumption. Ethanol virtually abolished the enhanced hepatocyte DNA synthesis induced by expression of the IRS-1 transgene.
CONCLUSIONS: Altered transmission of growth signals through the IRS-1-mediated signal transduction cascade may represent a molecular mechanism of how ethanol inhibits hepatocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834285     DOI: 10.1016/s0016-5085(98)70036-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance.

Authors:  Suzanne M de la Monte; Maoyin Pang; Rajeev Chaudhry; Kevin Duan; Lisa Longato; Jade Carter; Jiyun Ouh; Jack R Wands
Journal:  Hepatol Res       Date:  2011-02-24       Impact factor: 4.288

Review 2.  Cytokines and the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A M Diehl; Z P Li; H Z Lin; S Q Yang
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

3.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

4.  Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Authors:  Teresa Ramirez; Lisa Longato; Miroslav Dostalek; Ming Tong; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2012-09-20       Impact factor: 2.826

5.  Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice.

Authors:  Suthat Liangpunsakul; Yasmeen Rahmini; Ruth A Ross; Zhenwen Zhao; Yan Xu; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

6.  Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.

Authors:  Mashiko Setshedi; Lisa Longato; Dennis R Petersen; Martin Ronis; William C Chen; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

Review 7.  Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.

Authors:  Guofang Hou; Boran Xu; Yanghui Bi; Chuanlin Wu; Beibei Ru; Bei Sun; Xuewei Bai
Journal:  Bosn J Basic Med Sci       Date:  2018-11-05       Impact factor: 3.363

8.  Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.

Authors:  Sarah M Denucci; Ming Tong; Lisa Longato; Margot Lawton; Mashiko Setshedi; Rolf I Carlson; Jack R Wands; Suzanne M de la Monte
Journal:  Gastroenterol Res Pract       Date:  2010-08-16       Impact factor: 2.260

Review 9.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

Authors:  Kai Breuhahn; Peter Schirmacher
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 10.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.